M. Humbert (Paris, France), R. De Souza (Sao Paulo/Sp, Brazil)
Late Breaking Abstract - Long-term outcome of perioperative extracorporeal membrane oxygenation (ECMO) in patients undergoing pulmonary endarterectomy (PEA). E. Swietlik (Warszawa, Poland)
| |
Is there an obesity paradox in pulmonary arterial hypertension? J. Weatherald (Calgary, AB, Canada)
| |
Hispanic patients with pulmonary arterial hypertension: Preliminary results from a contemporary national registry J. Gomez-Arroyo (Cincinatti, United States of America)
| |
Supraventricular Arrhythmias in Pulmonary Arterial Hypertension V. Mercurio (Baltimore, United States of America)
| |
Effect of targeted therapies on survival of schistosomiasis associated pulmonary arterial hypertension B. Mamprim Piloto (SAO PAULO/SP, Brazil)
| |
Clinical phenotypes and outcomes of pulmonary hypertension due to left heart disease: role of the pre-capillary component S. Caravita (Milano, MI, Italy)
| |
Outcomes of patients with precapillary pulmonary hypertension admitted to an intensive care unit for acute right heart failure. L. Savale (Le Kremlin Bicêtre, France)
| |
Risk categories from European guidelines applied to the French Pulmonary Hypertension (PH) registry A. Boucly (PARIS, France)
| |
Multi-step therapy with riociguat, balloon pulmonary angioplasty, and cardiac rehabilitation for inoperable chronic thromboembolic pulmonary hypertension S. Fukui (Osaka, Japan)
| |
Poor Subpleural Perfusion as a predictor of Failure after Balloon Pulmonary Angioplasty for non-operable Chronic Thromboembolic Pulmonary Hypertension Y. Taniguchi (Paris, France)
| |
Audit of disease targeted therapies in adult patients with pulmonary arterial hypertension W. Gin-Sing (London, United Kingdom)
| |
Effect of long-term oxygen therapy on exercise capacity and quality of life in exercise-desaturating patients with pulmonary arterial or chronic thromboembolic pulmonary hypertension: a randomized-sham-controlled cross-over trial S. Ulrich (Zurich, Switzerland)
| |
Initial combination of macitentan and tadalafil in newly diagnosed patients with pulmonary arterial hypertension (PAH): results from the OPTIMA study O. Sitbon (Le Kremlin-Bicêtre, France)
| |
Safety and efficacy of immunoadsorption as an add-on to medical treatment in patients with idiopathic pulmonary arterial hypertension B. Egenlauf (Heidelberg, Germany)
| |
Safety of riociguat for the treatment of pulmonary hypertension: Data from the EXPERT registry H. Gall (Giessen, Germany)
| |
Transitioning pulmonary arterial hypertension patients from bosentan to macitentan: efficacy and safety data. M. Santos (Porto, Portugal)
| |
Prognostic impact of exercise pulmonary hypertension R. Oliveira (SAO PAULO/SP, Brazil)
| |